Carcinoid Syndrome
Lanreotide Effectively Controls Diarrhea, Flushing in Neuroendocrine Tumors
October 23, 2017Results of the double-blinded and initial open-label phases of the ELECT Study demonstrate the effectiveness of lanreotide in controlling diarrhea and flushing in patients with NETs presenting with carcinoid syndrome.
Cost of Care Significantly Increased With Carcinoid Syndrome in NETs
September 25, 2017Development of carcinoid syndrome has a profound effect on cost of care for patients with neuroendocrine tumors (NETs).
FDA Approves Supplemental Indication for Lanreotide Depot for Carcinoid Syndrome
September 19, 2017Patients who receieved lanreotide depot had a significantly lower percentage of days when rescue octreotide was used compared with placebo.
Lanreotide Eases Carcinoid Syndrome Symptoms in All Patients
June 04, 2017Lanreotide decreased the proportion of days patients had flushing and diarrhea compared with placebo, even in patients previously responsive to rescue therapy with octreotide.
Sign Up for Free e-newsletters
ONA Articles
- Skin Cancer Screening Programs: Are They Effective?
- Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- Prophylactic Cranial Irradiation in Small-Cell Lung Cancer: Update on Patient Selection, Efficacy and Outcomes
- Acrylamide in Food and Cancer Risk (Fact Sheet)
- Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers
- Skin Cancer Screening Programs: Are They Effective?
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Immune Checkpoint Inhibitors: A Review of Side Effects, Their Causes and Incidence
- ASCO Roundtable Addresses Clinical Trial Financial Burdens
- Cardiac Monitoring Advised for High-Risk Breast Cancer Patients
- United States Senate Passes Opioids Bill
- Estimating Quality of Life Based on Cumulative Drug Toxicity in Colorectal Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |